Stock Events

Stock Events

Altamira Therapeutics (CYTOF) Q1 2026 Earnings

31MarConfirmed

Q3 2024

Q2 2025

Q3 2025

Q1 2026

-2.38

-1.77

-1.15

-0.54

Details

Expected EPS

-0.647709979

Actual EPS

N/A

Surprise EPS

0.65

Surprise Percent

+100%

Description

Altamira Therapeutics (CYTOF) will report earnings of for Q1 2026 on March 31, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.